CA Stock MarketDetailed Quotes
APS Aptose Biosciences Inc
- 0.710
- -0.080-10.13%
15min DelayMarket Closed Aug 9 16:00 ET
12.86MMarket Cap-122P/E (TTM)
0.770High0.710Low2.00KVolume0.770Open0.790Pre Close1.46KTurnover6.20052wk High0.01%Turnover Ratio18.11MShares0.60052wk Low-5.8EPS TTM12.86MFloat Cap47520.000Historical HighLossP/E (Static)18.11MShs Float0.600Historical Low-10.048EPS LYR7.60%Amplitude--Dividend TTM71.00P/B1Lot Size--Div YieldTTM
Aptose Biosciences Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 57.21%-5.78M | -4.08%-11.76M | -37.96%-44.59M | -7.03%-9.26M | -50.97%-10.54M | -91.61%-13.5M | -17.18%-11.3M | 25.36%-32.32M | 46.08%-8.65M | 13.40%-6.98M |
| Net income from continuing operations | 48.67%-7.25M | 29.51%-9.64M | -22.44%-51.21M | -19.55%-11.96M | -17.08%-11.45M | -33.73%-14.13M | -19.12%-13.68M | 36.01%-41.82M | 58.89%-10M | 13.73%-9.78M |
| Operating gains losses | --66K | --10K | ---- | ---- | ---- | ---- | ---- | 385.71%20K | 366.67%16K | ---- |
| Depreciation and amortization | -10.53%102K | -16.79%109K | -11.74%466K | 10.00%110K | -21.28%111K | -19.15%114K | -10.27%131K | -15.11%528K | -38.65%100K | -9.03%141K |
| Unrealized gains and losses of investment securities | -50.00%1K | 75.00%-1K | ---- | ---- | -114.29%-1K | --2K | ---4K | ---- | ---- | --7K |
| Remuneration paid in stock | -73.08%207K | -56.83%809K | -29.84%3.65M | -52.26%411K | -43.11%599K | -1.28%769K | -25.46%1.87M | -59.79%5.21M | -62.79%861K | -42.40%1.05M |
| Other non cashItems | -84.48%9K | 40.00%28K | 45.36%-312K | 51.11%-329K | -125.61%-21K | 141.67%58K | 600.00%20K | -108.19%-571K | -109.70%-673K | 1,071.43%82K |
| Change In working capital | 443.53%1.09M | -971.95%-3.08M | -34.91%2.81M | 137.06%2.5M | -85.28%223K | -112.34%-317K | 142.94%353K | 184.76%4.32M | 193.28%1.06M | 18.36%1.52M |
| -Change in prepaid assets | 80.06%560K | -3.91%246K | 50.87%261K | 73.72%-385K | -96.48%29K | -48.08%311K | 19.63%256K | 121.79%173K | -1.60%-1.47M | 4.70%825K |
| -Change in payables and accrued expense | 207.39%567K | -2,511.54%-3.14M | -32.24%2.89M | 45.30%2.94M | -66.16%355K | -124.86%-528K | 114.05%130K | 195.98%4.27M | 2,061.17%2.02M | 68.92%1.05M |
| -Change in other current assets | 247.27%81K | -177.89%-74K | -176.61%-343K | -480.90%-339K | 80.44%-44K | -175.00%-55K | 196.88%95K | -3,000.00%-124K | 4,550.00%89K | -2,350.00%-225K |
| -Change in other current liabilities | -164.44%-119K | 10.16%-115K | ---- | ---- | 12.69%-117K | 66.42%-45K | 10.49%-128K | ---- | ---- | 3.60%-134K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 57.21%-5.78M | -4.08%-11.76M | -37.96%-44.59M | -7.03%-9.26M | -50.97%-10.54M | -91.61%-13.5M | -17.18%-11.3M | 25.36%-32.32M | 46.08%-8.65M | 13.40%-6.98M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 202.50%2.01M | 32.74%-1.99M | -66.87%9.96M | -88.97%1.94M | 355.08%12.95M | -119.47%-1.96M | -139.44%-2.96M | 185.40%30.07M | 187.82%17.57M | -2,644.86%-5.08M |
| Net PPE purchase and sale | 158.62%17K | --1K | -20.83%-29K | --0 | --0 | -20.83%-29K | --0 | 88.68%-24K | --0 | --0 |
| Net investment purchase and sale | 203.16%1.99M | 32.70%-1.99M | -66.80%9.99M | -88.97%1.94M | 355.08%12.95M | -119.14%-1.93M | -139.44%-2.96M | 185.98%30.09M | 187.88%17.57M | -126,850.00%-5.08M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 202.50%2.01M | 32.74%-1.99M | -66.87%9.96M | -88.97%1.94M | 355.08%12.95M | -119.47%-1.96M | -139.44%-2.96M | 185.40%30.07M | 187.82%17.57M | -2,644.86%-5.08M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 330.62%4.75M | 23,594.00%11.85M | 5,856.90%6.91M | 1,574.51%854K | 23,242.86%4.9M | 3,706.90%1.1M | 233.33%50K | -48.67%116K | -22.73%51K | 21K |
| Net common stock issuance | 344.63%4.93M | 34,691.18%11.83M | 6,712.87%6.88M | 1,554.90%844K | 23,204.76%4.89M | 3,724.14%1.11M | --34K | 180.56%101K | 41.67%51K | --21K |
| Proceeds from stock option exercised by employees | --0 | 12.50%18K | 93.33%29K | --0 | --13K | --0 | 6.67%16K | -92.11%15K | --0 | --0 |
| Net other financing activities | -3,440.00%-177K | ---- | ---- | ---- | ---5K | ---5K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 330.62%4.75M | 23,594.00%11.85M | 5,856.90%6.91M | 1,574.51%854K | 23,242.86%4.9M | 3,706.90%1.1M | 233.33%50K | -48.67%116K | -22.73%51K | --21K |
| Net cash flow | ||||||||||
| Beginning cash position | -67.73%7.35M | -74.97%9.25M | -5.48%36.97M | -43.84%15.72M | -79.02%8.4M | -38.47%22.76M | -5.48%36.97M | -66.68%39.11M | -62.73%27.99M | -51.96%40.03M |
| Current changes in cash | 106.86%985K | 86.58%-1.91M | -1,195.33%-27.72M | -172.07%-6.47M | 160.81%7.32M | -571.10%-14.36M | -568.80%-14.21M | 97.27%-2.14M | 124.93%8.97M | -46.00%-12.04M |
| Effect of exchange rate changes | 66.67%-1K | -75.00%1K | 150.00%2K | -116.67%-1K | 114.29%1K | 40.00%-3K | 100.00%4K | -157.14%-4K | -14.29%6K | -75.00%-7K |
| End cash Position | -0.83%8.33M | -67.73%7.35M | -74.97%9.25M | -74.97%9.25M | -43.84%15.72M | -79.02%8.4M | -38.47%22.76M | -5.48%36.97M | -5.48%36.97M | -62.73%27.99M |
| Free cash from | 57.30%-5.78M | -4.08%-11.76M | -37.94%-44.62M | -7.03%-9.26M | -50.97%-10.54M | -91.37%-13.53M | -17.18%-11.3M | 25.67%-32.35M | 46.13%-8.65M | 15.30%-6.98M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg